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Although there have been great achievements in the battle
against cancer over the past decades, cancer is still the
leading cause of death in developing countries like China.
Complementary and alternative medicine (CAM), especially
traditional Chinese medicine (TCM), usually having good
clinical tolerability, is applied as an adjuvant therapy to treat
cancer in China based on TCM or modern pharmacological
theories. In the west, CAM has increasingly become popular
in cancer patients. It is estimated that the United States
National Cancer Institute (NCI) spends around $120 million
each year on complementary and alternativemedicine related
research projects. However, a fact is that although a lot of
CAMs are widely used clinically, most evidence supporting
their use came from poorly reported published clinical
studies or studies with questionable methodology. Call for
high quality evidence is a mission of this special issue.
This issue on CAM for treatment or prevention of cancer
compiles 13 exciting manuscripts, most of which reporting
the efficacy and possible mechanisms of action of CAM or
active constituents on cancer prevention and/or therapy in
clinical and experimental levels.
S. S. M. Fong et al. contributed high quality evidence
about Tai Chi Qigong Training for balance performance in
irradiated survivors of nasopharyngeal cancer by a well-
designed, well-conducted, and well-reported randomized
controlled trial. Totally 120 senior adults participated in
the study voluntarily. In this cross-sectional exploratory
study, they have done very well on the ethics issues including
protocol approval by ethical committee, properly informed
consent, and high quality methodological issues, including
the randomization method and allocation procedure, the
recruitment of patients, the data management, the analysis
method of results. All of the procedures were conducted
according to the Declaration of Helsinki. This transparency
makes readers confident to trust the result of the study.
This is the first study to show that participating survivors
of NPC had inferior OLS balance performances in all of
the visual and supporting surface conditions compared with
age-matched healthy counterparts. TC Qigong might be a
potential rehabilitation exercise to improve the somatosen-
sory function and single-leg standing balance performance
of survivors of NPC. The shortcoming of this study is that
it uses a convenience sample which may have introduced
a self-selection bias that may threaten the internal validity
of the study. In addition, homogenous subject group, small
sample size, and OLS clinical test for balance performance
assessment may limit the generalizability of results. However,
we still believe that this study and its report could be a good
evidence for efficacy of CAMs.
This edition also includes a review that discusses the
possibility of TCM as maintenance therapy for advanced
nonsmall cell lung cancer. The review concludes that TCM
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as maintenance therapy can improve the QOL and prolong
the PFS of advanced NSCLC patients. Besides, TCM can
be applied for NSCLC patients not limited in population
selection. However, there are only small sample clinical trials
about TCM as maintenance therapy for advanced NSCLC.
More large-scale trials of TCM as maintenance therapy for
advanced NSCLC are expected.
For experimental study, A. Movahedi et al. investigated
the capability of the decoction of Teucrium polium L. from
Lamiaceae family to protect liver cells against hepatocellular
carcinoma in carcinogenesis-induced animal model. After
28 weeks of treatment, they found that serum biochemical
markers (ALT, AST, AFP, GGT, ALP, HCY, TNF-𝛼, 𝛼2MG,
and CBG), total antioxidant status, liver lesion, and gluco-
corticoid activity were all regulated auspiciously by Teucrium
polium L. Y. Lin et al. studied that elemene, a compound
found in an herb used in traditional Chinese medicine, has
the effect of protecting cancer cells from death either in
apatinib induced nutrient deficient environment or in serum-
free induced starvation. Further data on themechanism study
revealed that elemene induced protective autophagy and
prevented human hematoma cancer cells from undergoing
apoptosis.
In addition to the mentioned papers above, other studies
included in this issue provide sufficient scientific evidence
from CAM research to clarify their mechanism of action and
demonstrate their efficacy and safety. Through the rigorous
researches, the benefits of CAM therapies will be highlighted,
and this will support the clinical use of CAMs and help
integrating CAM into the mainstream medicine. We hope
that this special issue informs us about the rationale use of
CAM in cancer prevention and therapy. We also hope that
the papers included in this issue play a role in reflecting the
recent advancement in the field of CAM.
Peng Cao
Senthamil R. Selvan
Esra Ku¨peli Akkol
Ning Wang
Hongjun Yang
Xiaolan Cheng
